Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Non-Resectable Cholangiocarcinoma
A cholangiocarcinoma that is not amenable to surgical resection.
National Institutes of Health
Create Alert
Related topics
Related topics
12 relations
Abdominal Pain
Bile Duct Epithelium
Bile duct structure
Biliary tract structure
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Therapeutic effect of photodynamic therapy for nonresectable cholangiocarcinoma
Junjie Liu
,
P. Xue
,
J. Deng
Medicine
2018
Corpus ID: 3846923
Background: Cholangiocarcinoma is a malignant neoplasia that originates in the bile ducts. Most patients with cholangiocarcinoma…
Expand
Review
2017
Review
2017
Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis
Harsha Moole
,
Harsha Tathireddy
,
+7 authors
A. Duvvuri
World journal of gastroenterology
2017
Corpus ID: 37132423
AIM To perform a systematic review and meta-analysis on clinical outcomes of photodynamic therapy (PDT) in non-resectable…
Expand
Review
2016
Review
2016
Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma
R. Wentrup
,
Nicola Winkelmann
,
+5 authors
C. Buening
Gut and liver
2016
Corpus ID: 13981382
Background/Aims Standard treatments are not available for hilar nonresectable cholangiocarcinoma (NCC). It is unknown whether…
Expand
Review
2007
Review
2007
Role of Photodynamic Therapy in Gastroenterology
E. G. M. G. Karamanolis
2007
Corpus ID: 58748572
SUMMARY Photodynamic therapy (PDT) is a cancer treatment modality that combines the use of a photosensitizing agent and a…
Expand
Review
2006
Review
2006
Photodynamic therapy and Klatskin tumour: An overview
E. Rauws
Scandinavian journal of gastroenterology…
2006
Corpus ID: 21087090
The prognosis of patients with an unresectable bile duct cancer is poor. In 60–70% of patients, cholangiocarcinoma is located in…
Expand
Highly Cited
2005
Highly Cited
2005
Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma
G. Harewood
,
T. Baron
,
+4 authors
P. D. de Groen
Journal of gastroenterology and hepatology
2005
Corpus ID: 13260888
Background: Photodynamic therapy (PDT) has demonstrated promise in the palliative treatment of advanced cholangiocarcinoma. The…
Expand
Review
2004
Review
2004
Photodynamic therapy in cholangiocarcinomas.
Marianne E J Ortner
Best practice & research. Clinical…
2004
Corpus ID: 39605889
Symptoms occur late in cholangiocarcinoma and therefore only about half of the patients at the time of diagnosis are candidates…
Expand
Highly Cited
2003
Highly Cited
2003
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.
Marianne E J Ortner
,
K. Caca
,
+7 authors
H. Lochs
Gastroenterology
2003
Corpus ID: 2634227
BACKGROUND & AIMS In nonrandomized trials, photodynamic therapy (PDT) had a promising effect on nonresectable cholangiocarcinoma…
Expand
2001
2001
Photodynamic therapy (PDT) or non-resectable cholangiocarcinoma (CC) - first results of a randomized study
F. Berr
,
J. Liebetruth
,
+5 authors
M. Ortner
2001
Corpus ID: 58175418
Highly Cited
1996
Highly Cited
1996
A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma.
T. Bowling
,
S. Galbraith
,
A. Hatfield
,
J. Solano
,
M. Spittle
Gut
1996
Corpus ID: 572882
BACKGROUND AND AIMS: Radiotherapy has been reported to be of benefit in prolonging the survival of patients with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE